[HTML][HTML] Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation
J Styczynski - Infectious diseases and therapy, 2018 - Springer
Cytomegalovirus (CMV) is an agent of global infection, and its acquisition in a population is
characterized by an age-dependent rise in seropositivity. After primary infection, CMV …
characterized by an age-dependent rise in seropositivity. After primary infection, CMV …
Partners in crime: the role of CMV in immune dysregulation and clinical outcome during HIV infection
ML Freeman, MM Lederman, S Gianella - Current HIV/AIDS Reports, 2016 - Springer
In the current era of combination antiretroviral therapy (ART), human immunodeficiency virus
(HIV)-infected individuals are living longer and healthier lives. Nevertheless, HIV-infected …
(HIV)-infected individuals are living longer and healthier lives. Nevertheless, HIV-infected …
[图书][B] The selection and use of essential medicines: report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th …
Organisation mondiale de la santé. Comité d'experts … - 2015 - books.google.com
This report presents the recommendations of the WHO Expert Committee responsible for
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …
[HTML][HTML] CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living …
Background Immune restoration is often incomplete after ART in HIV patients, both
quantitatively and qualitatively. We studied the incidence and probability of CD4/CD8 …
quantitatively and qualitatively. We studied the incidence and probability of CD4/CD8 …
Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis
Symptomatic cytomegalovirus (CMV) disease has been the standard endpoint for clinical
trials in organ transplant recipients. Viral load may be a more relevant endpoint due to low …
trials in organ transplant recipients. Viral load may be a more relevant endpoint due to low …
Cytomegalovirus and HIV persistence: pouring gas on the fire
A Christensen-Quick, C Vanpouille, A Lisco… - AIDS Research and …, 2017 - liebertpub.com
The inherent stability of a small population of T cells that are latently infected with HIV
despite antiretroviral therapy (ART) remains a stubborn obstacle to an HIV cure. By …
despite antiretroviral therapy (ART) remains a stubborn obstacle to an HIV cure. By …
Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review
N Ford, Z Shubber, P Saranchuk… - Clinical infectious …, 2013 - academic.oup.com
Background. Cytomegalovirus (CMV) is a late-stage opportunistic infection in people living
with human immunodeficiency virus (HIV)/AIDS. Lack of ophthalmological diagnostic skills …
with human immunodeficiency virus (HIV)/AIDS. Lack of ophthalmological diagnostic skills …
Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing
AC Hearps, GE Martin, R Rajasuriar… - Current HIV/AIDS …, 2014 - Springer
Increased life expectancy due to improved efficacy of cART has uncovered an increased risk
of age-related morbidities in HIV+ individuals and catalyzed significant research into …
of age-related morbidities in HIV+ individuals and catalyzed significant research into …
TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4+ T cells
Objectives During chronic human immunodeficiency virus (HIV)‐1 infection, inhibitory
molecules upregulated on lymphocytes contribute to effector cell dysfunction and immune …
molecules upregulated on lymphocytes contribute to effector cell dysfunction and immune …
[HTML][HTML] Impaired polyfunctionality of CD8+ T cells in severe sepsis patients with human cytomegalovirus reactivation
Human cytomegalovirus (HCMV) establishes a lifelong chronic latent infection and often
reactivates in immunocompromised patients. In addition, HCMV reactivates in patients with …
reactivates in immunocompromised patients. In addition, HCMV reactivates in patients with …